Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet

Hormone and Metabolic Research

Volumn 38, Issue 6, 2006, Pages 417-422

  Fiore, C E ^a   Pennisi, P ^a   Ferro, G ^b   Ximenes, B ^b   Privitelli, L ^a   Mangiafico, R A ^a   Santoro, F ^a   Parisi, N ^a   Lombardo, T ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b S Bambino Hospital   (Italy)

Author keywords

Bone loss; Bone turnover; Celiac disease; Osteoprotegerin

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TELOPEPTIDE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE CELL; BONE DENSITOMETRY; BONE DENSITY; BONE INJURY; BONE TURNOVER; CELIAC DISEASE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMUR NECK; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUMBAR SPINE; OSSIFICATION; OSTEOLYSIS; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; FOLLOW-UP STUDIES; GLUTEN; GLYCOPROTEINS; HUMANS; LONG-TERM CARE; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33745959759     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944548     Document Type: Article

References (39)

1. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: 289-298
2. Bianchi ML, Bardella MT. Bone and celiac disease. Calcif Tissue Int 2002; 71: 465-471
3. Corazza GR, Di Stefano M, Maurino E, Bai JC. Bones in coeliac disease: diagnosis and treatment. Best Pract Res Clin Gastroenterol 2005; 19: 453-465
4. Pistorius LR, Sweidan WH, Purdie DW, Steel SA, Howey S, Bennett JR, Sutton DR. Coeliac disease and bone mineral density in adult female patients. Gut 1995; 37: 639-642
5. Vogelsang H, Suk EK, Janisiw M, Stain C, Mayr WR, Panzer S. Calcaneal ultrasound attenuation and vitamin-D-receptor genotypes in celiac disease. Scand J Gastroenterol 2000; 35: 172-176
6. Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457-461
7. Juergens JL, Scholz DA, Wollaeger EE. Severe osteomalacia associated with occult steatorrhea due to nontropical sprue; report of five cases. Arch Intern Med 1956; 98: 774-782
8. Molteni N, Bardell MT, Vezzoli G, Pozzoli E, Bianchi P. Intestinal calcium absorption as shown by stable strontium test in celiac disease before and after gluten-free diet. Am J Gastroenterol 1995; 90: 2025-2028
9. Ciacci C, Marelli L, Klain M, Savino G, Salvatore M, Mazzacca G, Cirillo M. Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol 1997; 92: 992-996
10. Selby PL, Davies M, Adams JE, Mawer EB. Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 1999; 14: 652-657
11. Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, Aliberti F, Facciuto E, Migliaccio S, Bardella MT, Dubini A, Borghi MO, Saraifoger S, Teti A, Bianchi ML. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004; 19: 1112-1121
12. Lemieux B, Boivin M, Brossard JH, Lepage R, Picard D, Rousseau L, D'Amour P. Normal parathyroid function with decreased bone mineral density in treated celiac disease. Can J Gastroenterol 2001; 15: 302-307
13. Pazianas M, Butcher GP, Subhani JM, Finch PJ, Ang L, Collins C, Heaney RP, Zaidi M, Maxwell JD. Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake. Osteoporos Int 2005; 16: 56-63
14. Fornari MC, Pedreira S, Niveloni S, Gonzales D, Diez RA, Vazquez H, Mazure R, Sugai E, Smecuol E, Boerr L, Maurino E, Bai JC. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998; 93: 413-418
15. Hofbauer LC. Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur J Endocrinol 1999; 141: 195-210
16. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 17: 93 (2): 165-176
17. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15: 2-12
18. Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, Jankovic L, Manni M, Morosetti M, Moscaritolo E, Sardella D, Bonucci E. Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 2002; 17: 233-238
19. Feuerherm AJ, Borset M, Seidel C, Sundan A, Leistad L, Ostensen M, Faxvaag A. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scand J Rheumatol 2001; 30: 229-234
20. Ueland T, Bollerslev J, Godang K, Muller F, Froland SS, Aukrust P. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess - possible role in bone homeostasis. Eur J Endocrinol 2001; 145: 685-690
21. Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J Hepatol 2003; 38: 395-400
22. Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Miner Res 2004; 19: 722-727
23. Stilgren LS, Rettmer E, Eriksen EF, Hegedus L, Beck-Nielsen H, Abrahamsen B. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Bone 2004; 35: 256-265
24. Maimoun L, Couret I, Mariano-Goulart D, Dupuy AM, Micallef JP, Peruchon E, Ohanna F, Cristol JP, Rossi M, Leroux JL. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury. Calcif Tissue Int 2005; 76: 404-411
25. Ciacci C, Cirillo M, Cavallaro R, Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002; 66: 178-185
26. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992; 102: 330-354
27. Wahab PJ, Meier JWR, Mulder CJJ. Histologic follow-up of people with Coeliac Disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002; 118: 459-463
28. Tursi A, Brandimarte G, Giorgetti GM, Gigliobianco A. Endoscopic features of celiac disease in adults and the correlation with age, histological damage, and clinical form of the disease. Endoscopy 2002; 34: 787-792
29. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978; 108: 161-175
30. Ireland P, Jolley D, Giles G, O'Dea K, Powkes J, Ritishauer I, Wahlquist ML, Williams J. A food frequency questionnaire for use in Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994; 3: 19-31
31. WHO Study Group. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO Tech Rep Ser, 1994; n° 843
32. McFarlane XA, Balla AK, Robertson DAF. Effect of a gluten-free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996; 39: 180-184
33. Kemppainen T, Kroger H, Janatuinen E, Arnala I, Lamberg-Allardt C, Karkkainen M, Kosma VM, Julkunen R, Jurvelin J, Alhava E, Uusitupa M. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 1999; 25: 355-360
34. Keaveny AP, Freaney R, McKenna MJ, Masterson J, O'Donoghue DP. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol 1996; 91: 1226-1231
35. Kontakou M, Przemioslo RT, Sturgess RP, Limb AG, Ciclitira PJ. Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol 1995; 30: 456-463
36. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002; 70 (1): 11-19
37. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513-523
38. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004; 292: 490-495
39. Fiore CE, Riccobene S, Mangiafico R, Santoro F, Pennisi P. Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. Osteoporos Int 2005; 16: 2180-2184